Americans are no longer content to let people go without health insurance.

The FDA found drug quality failures and worse in its inspection this spring of a Pfizer drug-making plant in China.

As the fate of the Patient Protection and Affordable Care Act seems assured, the debate has shifted to how to improve the law.

The growing campaign against Obamacare's tax on expensive health plans was to be expected. But this tax deals with a root problem in the U.S. health care system, and it would be better to fix its eminently fixable flaws than to kill it outright.